Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles.
Arris CE, Boyle FT, Calvert AH, Curtin NJ, Endicott JA, Garman EF, Gibson AE, Golding BT, Grant S, Griffin RJ, Jewsbury P, Johnson LN, Lawrie AM, Newell DR, Noble ME, Sausville EA, Schultz R, Yu W.
Arris CE, et al. Among authors: golding bt.
J Med Chem. 2000 Jul 27;43(15):2797-804. doi: 10.1021/jm990628o.
J Med Chem. 2000.
PMID: 10956187